CompletedPhase 4NCT00604955

Expand Access/Assess Safety and Efficacy of Paromomycin IM Injection for the Treatment of Visceral Leishmaniasis

Studying Leishmaniasis

Last synced from ClinicalTrials.gov April 1, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: PATH
Principal Investigator: P K Sinha, MD
Rajendra Memorial Research Institute of Medical Sciences
Intervention: Paromomycin sulfate(drug)
Enrollment: 2000 target
Eligibility: 2-55 years · All sexes
Timeline: 2007 – 2010

Study locations (7)

Rajendra Memorial Research Institute of Medical Sciences, Agam Kuan, Patna, Bihar, India
Shrimati Hazari Maternity and Medical Care, Azad Nagar, Balua Tal, Motihari, Bihar, India
Research Centre for Diabetes, Hypertension and Obesity, Bengali Tola, Samastipur, Bihar, India
Dr. A.K. Aditya Clinic, East of Bhola Talkies, Samastipur, Bihar, India
Kala-zar Research Centre, Patna, Bihar, India
Kala-azar Medical Research Centre, Rambagh Road, Muzaffarpur, Bihar, India
Kalazar Research Centre, Brahmpura, Muzaffarpur, Bihar, India

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT00604955 on ClinicalTrials.gov

Other trials for Leishmaniasis

Additional recruiting or active studies for the same condition.

See all trials for Leishmaniasis →

← Back to all trials